Literature DB >> 1176582

Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.

A W Meikle, J A Weed, F H Tyler.   

Abstract

To determine the kinetics of metabolism and interconversion of prednisolone and prednisone, the plasma levels of these synthetic glucocorticoids were measured by new radioimmunoassays (RIA) after intravenous (iv) or oral administration to normal humans. Following the iv injection of prednisolone phosphate in 8 normal subjects, the mean half-time of prednisolone was 240+/-20 min (mean+/-SE) and the metabolic clearance rate was 82+/-7.2 1/24 h/m2. Of 10 mg of prednisone given orally to 5 normal subjects, 69+/-5% was absorbed and converted to peripheral plasma prednisolone within 8 h. The data indicate that prednisone is extensively metabolized to prednisolone before it clears the splanchnic circulation and the formation prednisone by oxidation of the 11-hydorxyl group of prednisolone appears to occur mainly in peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1176582     DOI: 10.1210/jcem-41-4-717

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  The pharmacokinetics of trilostane and ketotrilostane in an interconverting system in the rat.

Authors:  J P McGee; P N Shaw
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

Review 2.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Alterations of glucocorticoid actions by other drugs and disease states.

Authors:  W Jubiz; A W Meikle
Journal:  Drugs       Date:  1979-08       Impact factor: 9.546

4.  Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone.

Authors:  Wendy C Bevier; Howard C Zisser; Lois Jovanovic; Daniel A Finan; Cesar C Palerm; Dale E Seborg; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2008-07

5.  Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.

Authors:  R G Henderson; T Wheatley; J English; J Chakraborty; V Marks
Journal:  Br Med J       Date:  1979-06-09

Review 6.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

7.  Prednisolone absorption in coeliac disease.

Authors:  M E Pickup; F Farah; J R Lowe; J S Dixon; C O Record
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

8.  Intra-individual consistency of prednisolone kinetics during long-term prednisone treatment.

Authors:  E Langhoff; H Flachs; J Ladefoged; E F Hvidberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 9.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

10.  Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.

Authors:  S J Szefler; W F Ebling; J W Georgitis; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.